Quote | IGM Biosciences Inc. (NYSE:IGMS)
Last: | $ |
---|---|
Change Percent: | -0.44% |
Open: | $43.21 |
Close: | $42.77 |
High: | $44.2387 |
Low: | $42.25 |
Volume: | 102,325 |
Last Trade Date Time: | 02/12/2020 04:43:38 pm |
News | IGM Biosciences Inc. (NYSE:IGMS)
2024-04-22 09:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-17 08:48:28 ET More on IGM Biosciences IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points IGM Biosciences GAAP EPS of -$1.01 beats by $0.08, revenue of $0.7M misses by $0.07M RBC Capital upgrades IGM Biosciences to outperform ...
Message Board Posts | IGM Biosciences Inc. (NYSE:IGMS)
Subject | By | Source | When |
---|---|---|---|
bears are running | crudeoil24 | investorshub | 06/21/2023 6:16:13 AM |
short squeeze signal | TheFinalCD | investorshub | 05/29/2023 1:56:07 PM |
AviseAnalytics: 5 THINGS YOU MUST KNOW ABOUT IGM BIOSCIENCES! $IGMS IGM Biosciences, Inc. (NASDAQ: | AviseAnalytics | investorshangout | 04/01/2022 1:02:41 PM |
Truist Reiterates Buy Rating, $80 Price Target. | crudeoil24 | investorshub | 03/29/2022 5:20:52 PM |
Let's see if $IGMS gets FDA phase | crudeoil24 | investorshub | 03/29/2022 4:57:42 PM |
News, Short Squeeze, Breakout and More Instantly...
IGM Biosciences Inc. Company Name:
IGMS Stock Symbol:
NYSE Market:
2024-04-22 09:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that the Company’s exclusive worldwide collaboration agreement with Sanofi to create and...
MOUNTAIN VIEW, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Stifel...